| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.08 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.093 | 0.08 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.09 |